Table 2.
Diets | |||||
---|---|---|---|---|---|
Symbol | Function | Control | 11% PPC | p-Value | |
Srebf1 | Transcription factor | 1.00 ± 0.35 | 0.77 ± 0.08 | 0.189 | |
Ppara | Transcription factor | 1.00 ± 0.34 | 1.65 ± 1.06 | 0.262 | |
Cd36/Fat | Fatty acid import | 1.00 ± 0.23 | 1.27 ± 0.51 | 0.339 | |
Cpt1a | β-oxidation | 1.00 ± 0.33 | 2.07 ± 1.22 | 0.092 | |
Cpt2 | β-oxidation | 1.00 ± 0.33 | 2.05 ± 1.19 | 0.118 | |
Cact/Slc25a20 | β-oxidation (transport) | 1.00 ± 0.19 | 1.53 ± 0.68 | 0.162 | |
Acox1 | β-oxidation | 1.00 ± 0.09 | 1.65 ± 0.44 | 0.017 | |
Hmgcs2 | Ketogenesis | 1.00 ± 0.23 | 1.38 ± 0.70 | 0.320 | |
Fasn | Fatty acid synthesis | 1.00 ± 0.71 | 0.37 ± 0.26 | 0.103 | |
Acaca | Fatty acid synthesis | 1.00 ± 0.53 | 0.71 ± 0.23 | 0.298 | |
Elo1 | Fatty acid elongation | 1.00 ± 0.10 | 1.06 ± 0.27 | 0.690 | |
Scd1 | Δ9 desaturation | 1.00 ± 0.61 | 0.94 ± 0.59 | 0.890 | |
Fads1 | ∆5 desaturation of fatty acids | 1.00 ± 0.18 | 0.53 ± 0.22 | 0.011 | |
Fads2 | Δ6 desaturation of fatty acids | 1.00 ± 0.25 | 0.62 ± 0.24 | 0.061 | |
ApoB | Cholesterol import | 1.00 ± 0.10 | 1.06 ± 0.20 | 0.617 | |
Ldlr | Cholesterol import | 1.00 ± 0.19 | 1.03 ± 0.37 | 0.898 | |
Hmgcr | Cholesterol synthesis | 1.00 ± 0.23 | 1.07± 0.19 | 0.636 | |
Cyp7a1 | Bile synthesis | 1.00 ± 0.43 | 1.91 ± 1.64 | 0.304 | |
Soat 1/Acat | Cholesterol ester formation | 1.00 ± 0.14 | 0.98 ± 0.31 | 0.888 | |
Gpam | TAG synthesis (glycerolipid synthesis) | 1.00 ± 0.20 | 0.88 ± 0.18 | 0.386 | |
Dgat | TAG synthesis | 1.00 ± 0.17 | 1.24 ± 0.26 | 0.166 | |
Mttp | Lipoprotein assembly | 1.00 ± 0.11 | 1.20 ± 0.34 | 0.301 | |
Lipc | Hepatisk lipase | 1.00 ± 0.13 | 0.98 ± 0.22 | 0.850 | |
Aadac | Triglycerid lipase activity | 1.00 ± 0.11 | 1.20 ± 0.19 | 0.112 | |
Sod2 | Mitochondrial antioxidant defense system | 1.00 ± 0.14 | 1.37 ± 0.26 | 0.038 |
PPC, phospholipid-protein complex. 1 All values were normalized to Rplp0 and values relative to control are shown as means ± SD (n = 5 in control, n = 6 in 11% PPC). Results were analyzed by unpaired t-test, with significant p-values in bold (p ≤ 0.05). Abbreviations: Aadac, arylacetamide deacetylase; Acaca, acetyl-coA-carboxylase alpha; Acox1, acyl-CoA oxidase 1 palmitoyl; ApoB, apoprotein B; Cact/Slc25a20, carnitine-acylcarnitine translocase; Cd36/Fat, CD36 antigen/fatty acid translocase; Cpt1a, carnitine palmitoyltransferase 1A; Cpt2, carnitine palmitoyltransferase 2; Cyp7a1, cytochrome P450 family 7 subfamily A polypeptide 1; Dgat, diacylglycerol O-acyltransferase 1; Elo1, fatty acid elongase 1; Fads1, delta 5 desaturase/fatty acid desaturase 1; Fads2, delta 6 desaturase/fatty acid desaturase 2; Fasn, fatty acid synthase; Gpam, glycerol-3-phosphate acyltransferase mitochondrial; Hmgcr, 3-hydroxy-3-methylglutaryl-CoA reductase; Hmgcs2, 3-hydroxy-3-methylglutaryl-CoA synthase 2; Ldlr, low density lipoprotein receptor; Lipc, lipase hepatic; Mttp, microsomal triglyceride transfer protein; Ppara, peroxisome proliferator activated receptor alpha; Scd1, stearoyl-coenzyme A desaturase 1; Soat/Acat, sterol-O-acyltransferase 1/acyl-CoA:cholesterol acyltransferase; Sod2, superoxide dismutase 2, mitochondrial; Srebf1, sterol regulatory element binding transcription factor 1.